References
- Skinner DW, Van Hasselt CA. Nasopharyngeal carcinoma: methods of presentation. Ear Nose Throat J 1990; 69: 237–40
- Dickson RI. Nasopharyngeal carcinoma: an evaluation of 209 patients. Laryngoscope 1981; 91: 333–54
- Tang NL, Choy AT, John DG, van Hasselt CA. The otological status of patients with nasopharyngeal carcinoma after megavoltage radiotherapy. J Laryngol Otol 1992; 106: 1055–8
- Low WK, Fong KW. Hearing disability before and after radiotherapy for nasopharyngeal carcinoma. J Laryngol Otol 1996; 110: 121–3
- King AD, Kew J, Tong M, Leung SF, Lam WW, Metreweli C, et al. Magnetic resonance imaging of the eustachian tube in nasopharyngeal carcinoma: correlation of patterns of spread with middle ear effusion. Am J Otol 1999; 20: 69–73
- Strauss M, Towfighi J, Lord S, Lipton A, Harvey HA, Brown B. Cis-platinum ototoxicity: clinical experience and temporal bone histopathology. Laryngoscope 1983; 93: 1554–9
- Hinojosa R, Riggs LC, Strauss M, Matz GJ. Temporal bone histopathology of cisplatinum ototoxicity. Am J Otol 1995; 16: 731–40
- Hoistad DL, Ondrey FG, Mutlu C, Schachern PA, Paparella MM, Adams GL. Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg 1998; 118: 825–32
- van Ruijven MW, de Groot JC, Klis SF, Smoorenburg GF. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res 2005; 205: 241–8
- Tokimoto T, Kanagawa K. Effects of X-ray irradiation on hearing in guinea pigs. Acta Otolaryngol (Stockh) 1985; 100: 266–72
- Winther FO. X-ray irradiation of the inner ear of the guinea pig. An electron microscopic study of the degenerating outer hair cells of the organ of Corti. Acta Otolaryngol (Stockh) 1970; 69: 61–76
- Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT, et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 1996; 36: 281–9
- Oh YT, Kim CH, Choi JH, Kang SH, Chun M. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol 2004; 72: 79–82
- Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY. Sensorineural hearing loss after radiotherapy and chemotherapy: a single, blinded, randomized study. J Clin Oncol 2006; 24: 1904–9
- Rademaker-Lakhai JM, Crul M, Zuur L, Baas P, Beijnen JH, Simis YJ, et al. Relationship between cisplatin administration and the development of ototoxicity. J Clin Oncol 2006; 24: 918–24
- Wright CG, Schaefer SD. Inner ear histopathology in patients treated with cis-platinum. Laryngoscope 1982; 92: 1408–13